With do-it-yourself CRISPR kits now available online, Hannah Devlin asks if it’s really possible to edit your own DNA, is it safe and how should it be regulated?
Fighting back against President Donald Trump’s one-two punch to NIH funding: researchers will be key to those efforts, President of Research!America says
Two years on from their first show about CRISPR, the “ninja-assassin-meets-DNA-editing-tool”, Radiolab revisits the crazy world of gene editing
Whether it’s when commuting to work or while walking the dog, it’s always good with some entertainment. It’s even better when it can make you smarter at the same time! We’ve made a list of five podcasts that are worth a listen
Molecular biologist Maryam Zaringhalam discovers something strange about her sense of smell, and Hillary Savoie’s daughter is born with a rare genetic mutation.
Latest episode of Genentech’s podcast looks a new generation of “super antibiotics” could hold the key to overcoming antibiotic resistance
The latest episode of Genentech’s new show (Two Scientists Walk Into A Bar) looks at cell to cell communication, and what goes wrong when disease strikes
Have you ever considered starting your own biotech business? You may be in for a surprise…
Many of you will be out and about exercising your voting rights today, so we decided to share a little election day podcast for your listening pleasure
Signal podcast takes a look at an area of gene editing receiving a lot of attention and debate: the fight against vector-borne disease
…and you’ll never guess what happens next! Actually, what happens is a fantastic new podcast about the biggest challenges in human biology
New episode of Signal podcast calls shenanigans on the tactics that drug companies use to stay ahead in the market
The latest episode of Signal podcast from STAT News looks at the scientists and clinicians engaged in a frantic race to develop a Zika vaccine
In the latest episode of Signal, Meg Tirrell and Luke Timmerman delve into the problem of antibiotic resistance
“We don’t want to be sought out because we’re women. We want to be sought out because we’re awesome.”
The latest episode from Signal gets inside the thorny issue of sexism in biotech